Personal information

Other IDs

SciProfiles: 1151847

Activities

Collapse all

Employment (1)

Sapienza University of Rome: Rome, Lazio, IT

1990-01-01 to present | Dr. (Cellular Biotechnologies and Haematology)
Employment
Source: Self-asserted source
Antonio CHISTOLINI

Works (24)

Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers

Annals of Hematology
2024-11 | Journal article
DOI: 10.1007/s00277-024-06021-2
Contributors: Alessandro Laganà; Silvia Sorella; Ludovica Fucci; Cristina Santoro; Silvio Ligia; Rosaria Mormile; Erminia Baldacci; Antonio Chistolini
Source: check_circle
Crossref

Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

British Journal of Haematology
2024-05 | Journal article
DOI: 10.1111/bjh.19450
Contributors: Mauro Passucci; Alessandro Laganà; Livia Donzelli; Chiara Masucci; Angelo Genoese; Antonio Chistolini; Erminia Baldacci; Cristina Santoro
Source: check_circle
Crossref

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry

Journal of Clinical Medicine
2024-03-29 | Journal article
DOI: 10.3390/jcm13072009
Contributors: Daniela Poli; Emilia Antonucci; Walter Ageno; Martina Berteotti; Anna Falanga; Vittorio Pengo; Paolo Chiarugi; Benilde Cosmi; Carmelo Paparo; Antonio Chistolini et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study

Journal of Clinical Medicine
2024-02-27 | Journal article
DOI: 10.3390/jcm13051343
Contributors: Gualtiero Palareti; Emilia Antonucci; Eugenio Bucherini; Antonella Caronna; Antonio Chistolini; Angela Di Giorgio; Rosella Di Giulio; Anna Falanga; Vittorio Fregoni; Mariagrazia Garzia et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients

Annals of Hematology
2023-09 | Journal article
DOI: 10.1007/s00277-023-05369-1
Contributors: A. Chistolini; A. Serrao; G.M. Assanto; A. Genoese; E. Baldacci; S. Ligia; M. Breccia; C. Santoro
Source: check_circle
Crossref

Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients

Thrombosis and Haemostasis
2023-01 | Journal article
DOI: 10.1055/a-1962-5447
Contributors: Lucia Stefanini; Franco Ruberto; Mariaignazia Curreli; Antonio Chistolini; Eleonora Schiera; Ramona Marrapodi; Marcella Visentini; Giancarlo Ceccarelli; Gabriella D'Ettorre; Cristina Santoro et al.
Source: check_circle
Crossref

Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies

Journal of Thrombosis and Thrombolysis
2022-11 | Journal article
DOI: 10.1007/s11239-022-02702-9
Contributors: Alessandra Serrao; Francesco Malfona; Giovanni Manfredi Assanto; Maria Gabriela Chavez Orellana; Cristina Santoro; Antonio Chistolini
Source: check_circle
Crossref

“Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients—30 months follow‐up”: Comment from Serrao et al.

Journal of Thrombosis and Haemostasis
2022-08 | Journal article
DOI: 10.1111/jth.15775
Contributors: Alessandra Serrao; Giovanni Manfredi Assanto; Francesco Malfona; Gabriela Chavez Orellana; Antonio Chistolini
Source: check_circle
Crossref

Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study

Biomolecules
2022-08-07 | Journal article
DOI: 10.3390/biom12081088
Contributors: Fulvia Ceccarelli; Francesco Natalucci; Giulio Olivieri; Carmelo Pirone; Licia Picciariello; Valeria Orefice; Simona Truglia; Francesca Romana Spinelli; Cristiano Alessandri; Antonio Chistolini et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register

TH Open
2022-07 | Journal article
DOI: 10.1055/a-1878-6806
Contributors: Daniela Poli; Emilia Antonucci; Walter Ageno; Paolo Prandoni; Giovanni Barillari; Giuseppina Bitti; Egidio Imbalzano; Eugenio Bucherini; Antonio Chistolini; Vittorio Fregoni et al.
Source: check_circle
Crossref

Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients

Internal and Emergency Medicine
2022-06 | Journal article
DOI: 10.1007/s11739-021-02917-3
Contributors: Alessandra Serrao; Giovanni Manfredi Assanto; Rosaria Mormile; Mattia Brescini; Cristina Santoro; Antonio Chistolini
Source: check_circle
Crossref

Thromboembolic events following mRNA vaccines for COVID 19: a case series

Journal of Thrombosis and Thrombolysis
2022-05 | Journal article
DOI: 10.1007/s11239-021-02627-9
Contributors: Alessandra Serrao; Roberta Agrippino; Mattia Brescini; Rosaria Mormile; Antonio Chistolini
Source: check_circle
Crossref

Vaccine-induced immune thrombotic thrombocytopenia and spike protein

2021-09-17 | Other
DOI: 10.21203/rs.3.rs-887779/v1
Contributors: Manuela De Michele; Paola Piscopo; Alessio Crestini; Roberto Rivabene; Giulia d'Amati; Martina Leopizzi; Lucia Stefanini; Davide Flego; Fabio Pulcinelli; Antonio Chistolini et al.
Source: check_circle
Crossref

Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?

Journal of Thrombosis and Thrombolysis
2021-08-08 | Journal article
DOI: 10.1007/s11239-020-02354-7
Contributors: Gianfranco Lapietra; Alessandra Serrao; Francesca Fazio; Maria Teresa Petrucci; Antonio Chistolini
Source: check_circle
Crossref

Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia

Nature Communications
2021-08-02 | Journal article
DOI: 10.1038/s41467-021-25010-x
Contributors: M. De Michele; M. Iacobucci; A. Chistolini; E. Nicolini; F. Pulcinelli; B. Cerbelli; E. Merenda; O. G. Schiavo; E. Sbardella; I. Berto et al.
Source: check_circle
Crossref

The treatment of upper extremities deep vein thrombosis related to thoracic outlet syndrome with direct oral anticoagulants

Phlebology: The Journal of Venous Disease
2021-05 | Journal article
DOI: 10.1177/0268355520967519
Contributors: Luciano Fiori; Alessandra Serrao; Antonietta Ferretti; Antonio Chistolini
Source: check_circle
Crossref

Post-filter thromboembolic prophylaxis in vena cava filter carriers

Phlebology: The Journal of Venous Disease
2021-02 | Journal article
DOI: 10.1177/0268355520938580
Contributors: Alessandra Serrao; Luciano Fiori; Antonio Chistolini
Source: check_circle
Crossref

Outcomes of long‐term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis

European Journal of Clinical Investigation
2021-01 | Journal article
DOI: 10.1111/eci.13356
Contributors: Alessandra Serrao; Manuela Merli; Benedetta Lucani; Francesca Aprile; Luciano Fiori; Stefania Gioia; Massimo Breccia; Olivero Riggio; Antonio Chistolini
Source: check_circle
Crossref

A multicenter real‐life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph‐negative myeloproliferative neoplasms

American Journal of Hematology
2020-12 | Journal article
DOI: 10.1002/ajh.25990
Contributors: Alessandra Serrao; Massimo Breccia; Mariasanta Napolitano; Luciano Fiori; Marco Santoro; Emilia Scalzulli; Michelina Santopietro; Cristina Santoro; Simona Raso; Antonio Chistolini
Source: check_circle
Crossref

Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Clinical Drug Investigation
2020-12-22 | Journal article
DOI: 10.1007/s40261-020-00980-w
Contributors: Alessandra Serrao; Emilia Scalzulli; Luciano Fiori; Alessio Di Prima; Massimo Breccia; Antonio Chistolini
Source: check_circle
Crossref

Direct oral anticoagulants for the treatment of Mondor’s disease not responding to low-molecular weight heparin

Phlebology: The Journal of Venous Disease
2020-10 | Journal article
DOI: 10.1177/0268355520925022
Contributors: Alessandra Serrao; Benedetta Lucani; Erminia Baldacci; Luciano Fiori; Antonio Chistolini
Source: check_circle
Crossref

Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19

British Journal of Haematology
2020-08 | Journal article
DOI: 10.1111/bjh.17003
Contributors: Antonio Chistolini; Franco Ruberto; Francesco Alessandri; Cristina Santoro; Francesco Barone; Maria Cristina Puzzolo; Giancarlo Ceccarelli; Maria L. De Luca; Massimo Mancone; Domenico Alvaro et al.
Source: check_circle
Crossref

PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count

Journal of Thrombosis and Thrombolysis
2020-04-24 | Journal article
DOI: 10.1007/s11239-020-02040-8
Contributors: Maria Cristina Scamuffa; Salvatore Giacomo Morano; Alessandra Serrao; Antonella Bruzzese; Francesca Stocchi; Cristina Santoro; Federico Vozella; Roberto Latagliata; Antonio Chistolini
Source: check_circle
Crossref

Use of edoxaban for the treatment of venous thromboembolism in HIV‐infected patients

HIV Medicine
2020-03 | Journal article
DOI: 10.1111/hiv.12803
Contributors: Alessandra Serrao; Cristina Santoro; Robin Foà; Antonio Chistolini
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Annals of hematology. (1)
Review activity for Hemato (1)
How many people are using ORCID?